Deferred Tax Assets, Valuation Allowance of Gossamer Bio, Inc. from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Gossamer Bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2017 to 31 Dec 2024.
  • Gossamer Bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $228,683,000, a 3.3% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Gossamer Bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $228,683,000 +$7,290,000 +3.3% 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q4 2023 $221,393,000 +$17,343,000 +8.5% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q4 2022 $204,050,000 +$56,348,000 +38% 31 Dec 2022 10-K 13 Mar 2025 2024 FY
Q4 2021 $147,702,000 +$46,044,000 +45% 31 Dec 2021 10-K 05 Mar 2024 2023 FY
Q4 2020 $101,658,000 +$38,884,000 +62% 31 Dec 2020 10-K 17 Mar 2023 2022 FY
Q4 2019 $62,774,000 +$41,019,000 +189% 31 Dec 2019 10-K 03 Mar 2022 2021 FY
Q4 2018 $21,755,000 +$19,860,000 +1048% 31 Dec 2018 10-K 26 Feb 2021 2020 FY
Q4 2017 $1,895,000 31 Dec 2017 10-K 24 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.